ResMed RSMDF Stock
ResMed Price Chart
ResMed RSMDF Financial and Trading Overview
| ResMed stock price | 22.61 USD |
| Previous Close | 22.61 USD |
| Open | 22.48 USD |
| Bid | 19.65 USD x 10000 |
| Ask | 24.6 USD x 10000 |
| Day's Range | 22.48 - 22.48 USD |
| 52 Week Range | 11.85 - 28.25 USD |
| Volume | 100 USD |
| Avg. Volume | 26 USD |
| Market Cap | 31.8B USD |
| Beta (5Y Monthly) | 0.766 |
| PE Ratio (TTM) | 21.740385 |
| EPS (TTM) | 1.04 USD |
| Forward Dividend & Yield | 0.26 (1.16%) |
| Ex-Dividend Date | August 19, 2026 |
| 1y Target Est | N/A |
RSMDF Valuation Measures
| Enterprise Value | 12.4B USD |
| Trailing P/E | 21.740385 |
| Forward P/E | 55.146343 |
| PEG Ratio (5 yr expected) | 1.31 |
| Price/Sales (ttm) | 5.6246314 |
| Price/Book (mrq) | 1.9809008 |
| Enterprise Value/Revenue | 2.194 |
| Enterprise Value/EBITDA | 5.918 |
Trading Information
ResMed Stock Price History
| Beta (5Y Monthly) | 0.766 |
| 52-Week Change | -8.75% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 28.25 USD |
| 52 Week Low | 11.85 USD |
| 50-Day Moving Average | 21.32 USD |
| 200-Day Moving Average | 22.06 USD |
RSMDF Share Statistics
| Avg. Volume (3 month) | 26 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 1.41B |
| Float | 573.45M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 9.52% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.4 |
| Trailing Annual Dividend Yield | 10.61% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2301 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 26.94% |
| Operating Margin (ttm) | 30.85% |
| Gross Margin | 61.61% |
| EBITDA Margin | 37.07% |
Management Effectiveness
| Return on Assets (ttm) | 14.00% |
| Return on Equity (ttm) | 24.26% |
Income Statement
| Revenue (ttm) | 5.65B USD |
| Revenue Per Share (ttm) | 9.71 USD |
| Quarterly Revenue Growth (yoy) | 8.59% |
| Gross Profit (ttm) | 3.48B USD |
| EBITDA | 2.1B USD |
| Net Income Avi to Common (ttm) | 1.52B USD |
| Diluted EPS (ttm) | 1.04 |
| Quarterly Earnings Growth (yoy) | 1.00% |
Balance Sheet
| Total Cash (mrq) | 1.47B USD |
| Total Cash Per Share (mrq) | 2.55 USD |
| Total Debt (mrq) | 825.92M USD |
| Total Debt/Equity (mrq) | 12.54 USD |
| Current Ratio (mrq) | 3.1 |
| Book Value Per Share (mrq) | 11.414 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.81B USD |
| Levered Free Cash Flow (ttm) | 939.25M USD |
Profile of ResMed
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 9001 Spectrum Center Boulevard |
| ZIP | 92123 |
| Phone | 858-836-5000 |
| Website | https://www.resmed.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 11370 |
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Q&A For ResMed Stock
What is a current RSMDF stock price?
ResMed RSMDF stock price today per share is 22.61 USD.
How to purchase ResMed stock?
You can buy RSMDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ResMed?
The stock symbol or ticker of ResMed is RSMDF.
Which industry does the ResMed company belong to?
The ResMed industry is Medical Instruments & Supplies.
How many shares does ResMed have in circulation?
The max supply of ResMed shares is 1.41B.
What is ResMed Price to Earnings Ratio (PE Ratio)?
ResMed PE Ratio is 21.74038500 now.
What was ResMed earnings per share over the trailing 12 months (TTM)?
ResMed EPS is 1.04 USD over the trailing 12 months.
Which sector does the ResMed company belong to?
The ResMed sector is Healthcare.
